NASDAQ:CUE

Cue Biopharma Stock Predictions

etoro logo Buy CUE
*Your capital is at risk
$26.91
-1.71 (-5.97%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CUE Prediction Chart

CUE Predictions History

Latest community submissions for CUE.
Predictor Target Session Target Price Result Direction Accuracy Score
May 5, 2026 $28.66 -4.00% $34.94 X 82.01% 0
May 5, 2026 $27.46 -8.01% $34.94 X 78.59% 0
May 5, 2026 $28.36 -5.00% $34.94 X 81.16% 0
May 5, 2026 Bullish $34.94 V 1
Oct 22, 2025 $0.80 -96.76% $0.765 V 95.05% 1
Oct 22, 2025 $0.81 -96.72% $0.765 V 93.98% 1
Oct 22, 2025 Bullish $0.765 X 0
Jul 8, 2024 $1.02 -96.44% $0.98 X 95.14% 1
Jul 8, 2024 $1.00 -96.53% $0.98 X 97.61% 1
Jul 28, 2023 $3.80 -96.57% $3.84 X 98.93% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CUE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CUE BIOPHARMA INC.
Cue Biopharma
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-10...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE